EU/USA: “Production of the B61-12 nuclear bomb begins,” Sandia National Laboratories announced from the United States. The B61-12, which replaces the previous B61 deployed by the U.S. at Aviano and Ghedi and other European bases, is a new type of weapon. It has a nuclear warhead with four power options, selectable depending on the target to be destroyed. It is not dropped vertically, but at a distance from the target on which it is directed guided by a satellite system. It can penetrate underground, exploding deep to destroy command center bunkers in a nuclear first strike.
The B61-12s, classified as “non-strategic nuclear weapons,” are deployed in Europe — in Italy, Germany, Belgium, the Netherlands, Britain and probably other countries — at distances far enough to strike Russia. They thus have offensive capabilities similar to those of strategic weapons.
Another nuclear weapon system, which the United States is preparing to install in Europe against Russia, is ground-based intermediate-range missiles. They can also be launched from “anti-missile shield” installations, deployed by the U.S. at bases in Deveselu in Romania and Redzikowo in Poland, and aboard five warships cruising in the Mediterranean, Black Sea and Baltic Sea close to Russia.
That such installations have offensive capabilities is confirmed by Lockheed Martin itself. Outlining the characteristics of the Mk 41 vertical launch system, used in both land and naval installations, it specifies that it is capable of launching “missiles for all missions, both defense and long-range attack, including Tomahawk cruise missiles.” These can be armed with nuclear warheads.
Europe is thus being turned by the U.S. into the front line of a nuclear confrontation with Russia, even more dangerous than that of the Cold War.
by Manlio Dinucci.
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post